Navigation Links
Creator of Recon Moutaineer's Tactical Combat Casualty Care Bag Praises Combat Lifesavers
Date:7/14/2008

Service Disabled Veteran Owned Business Offers Premier Combat Lifesaver

Equipment

OCEANSIDE, Calif., July 14 /PRNewswire/ -- In the summer of 2005, the U.S. Army approached Recon Mountaineer(R) LLC (RMLLC) to design a medical bag to accommodate the requirements for the Combat Lifesaver program, and at gaining their approval, the TC3(R) or Tactical Combat Casualty Care Bag, NSN: 6545-01-537-0686, was developed.

http://www.reconmountaineer.com/PDF_flyers/ReconMountaineerTC3-V1.pdf

"Words could never be enough and the real thank you goes out to you, the service men and women that have taken up the challenge to be the 'Angels of the Golden Hour.' We appreciate your sacrifice and steadfastness in saving lives. Thank you for trusting us to design this equipment for you. RMLLC looks forward to the future and continuing to design medical equipment for our warriors," stated RMLLC founder D.A. "Mack" Mlynek.

The TC3(R) was designated by USAMMA, short for the United States Army Medical Materials Agency, to be a component within their fielded Combat Lifesaver medical suite. RMLLC would also like to thank USAMMA for the trust and confidence shown to RMLLC to design and manufacture this equipment. The TC3(R) has been manufactured and in service with the U.S. Army since the end of 2005 and has been receiving outstanding reviews.

"Word of caution to all end-users, if it (The TC3(R)) does not have Recon Mountaineer(R) LLC and the company phone number, (760) 207-0056, on the back of this equipment, RMLLC did not make it or authorize it. Send it back and ask for the original TC3(R) made by the designer. The quality of the equipment designed and manufactured by RMLLC speaks for itself -- not to mention the fantastic pricing," said Mlynek.

About RMLLC

Recon Mountaineer(R) LLC was established in October of 2002 by a Service Disabled Veteran by the name of D.A. "Mack" Mlynek, originally from Wyoming and Colorado. Mack served in the Marine Corps for about 24 years as a Recon Marine. After retirement and despite being labeled a Service Disabled Veteran, he started a new business to design equipment for the warrior in harm's way. The idea was to create new equipment designs that would greatly diminish the possibilities of acquiring disabilities later in life, but to also greatly enhance the user's efficiency now.

Recon Mountaineer(R) LLC now asks for your comments. Contact Mack Mlynek at 760-207-0056 or Mack@reconmountaineer.com.

Website: http://www.reconmountaineer.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Recon Mountaineer(R) LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Creator of PubMed Central biomedical research database recognized for outstanding citizen service
2. Dr. Siegals(R) COOKIE DIET(TM) Creator Sanford Siegal, D.O., M.D., Weighs In on Madonnas My husband didnt want to have sex on the cookie diet Remarks
3. Two Little Hands Productions, Creators of Popular Childrens TV Series Signing Time, Debuts Second Season at This Years Toy Fair 2008
4. YOU: Staying Young Fourth New York Times Best-Seller for RealAge Test Creator Dr. Michael Roizen!
5. Fruit 66 Creator Takes the High Road to Create a Healthy Drink for Students
6. New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
7. ACL Reconstruction With Cadaver Tissue Risky in Younger Patients
8. New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
9. Cadaver tissue fails nearly 25 percent of the time in young ACL reconstructions
10. 98% of Elective Mastectomy Patients Would Have Reconstruction Again, Says ASPS Study
11. 98 percent of elective mastectomy patients would have reconstruction again, says ASPS study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: